6 insiders reported 19 Form 4 transactions for Bionano Genomics, Inc. (BNGO) over the past 18 months (most recent 2026-09-09). Recent activity: Luderer Albert (Interim Chief Executive) Buy 4,000 shares, Luderer Albert (Interim Chief Executive) Buy 4,000 shares, Adamchak Mark (Principal Accounting Officer) Sell 7 shares, Chaubey Alka (CHIEF MEDICAL OFFICER) Sell 24 shares, Dixon Jonathan V. (GENERAL COUNSEL) Sell 24 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-09 | Luderer Albert | Interim Chief Executive | Buy | 4,000 | $4,845 |
| 2026-08-21 | Luderer Albert | Interim Chief Executive | Buy | 4,000 | $4,860 |
| 2026-06-03 | Adamchak Mark | Principal Accounting Officer | Sell | 7 | $9 |
| 2026-06-03 | Chaubey Alka | CHIEF MEDICAL OFFICER | Sell | 24 | $31 |
| 2026-06-03 | Dixon Jonathan V. | GENERAL COUNSEL | Sell | 24 | $31 |
| 2026-06-03 | OLDAKOWSKI MARK | CHIEF OPERATING OFFICER | Sell | 27 | $35 |
| 2026-02-18 | OLDAKOWSKI MARK | CHIEF OPERATING OFFICER | Sell | 20 | $22 |
| 2026-02-18 | Dixon Jonathan V. | GENERAL COUNSEL | Sell | 6 | $7 |
| 2026-02-18 | Holmlin R. Erik | PRESIDENT AND CEO | Sell | 51 | $56 |
| 2026-02-18 | Chaubey Alka | CHIEF MEDICAL OFFICER | Sell | 18 | $20 |
| 2026-02-18 | Adamchak Mark | Principal Accounting Officer | Sell | 3 | $3 |
| 2025-09-12 | Chaubey Alka | Chief Medical Officer | Sell | 51 | $207 |
| 2025-09-12 | OLDAKOWSKI MARK | Chief Operating Officer | Sell | 59 | $240 |
| 2025-09-12 | OLDAKOWSKI MARK | Chief Operating Officer | Sell | 59 | $240 |
| 2025-06-03 | OLDAKOWSKI MARK | Chief Operating Officer | Sell | 27 | $100 |
| 2025-06-03 | Holmlin R. Erik | President and CEO | Sell | 75 | $277 |
| 2025-06-03 | Chaubey Alka | Chief Medical Officer | Sell | 24 | $89 |
| 2025-06-03 | Dixon Jonathan V. | General Counsel | Sell | 25 | $92 |
| 2025-06-03 | Adamchak Mark | Principal Accounting Officer | Sell | 7 | $26 |
Source: SEC Form 4 filings · as of 2026-09-09